Halozyme Therapeutics
HALO
#2006
Rank
NZ$13.62 B
Marketcap
$110.28
Share price
1.86%
Change (1 day)
62.83%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: NZ$13.62 Billion

As of April 2025 Halozyme Therapeutics has a market cap of NZ$13.62 Billion. This makes Halozyme Therapeutics the world's 2006th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$13.62 B25.48%
2024NZ$10.85 B40.64%
2023NZ$7.72 B-36.29%
2022NZ$12.11 B46.21%
2021NZ$8.28 B3.58%
2020NZ$8.00 B122.33%
2019NZ$3.59 B14.02%
2018NZ$3.15 B-22.27%
2017NZ$4.06 B119.88%
2016NZ$1.84 B-43.08%
2015NZ$3.24 B109.56%
2014NZ$1.54 B-25.89%
2013NZ$2.08 B127.26%
2012NZ$0.91 B-27.24%
2011NZ$1.26 B22.37%
2010NZ$1.03 B39.35%
2009NZ$0.74 B-5.72%
2008NZ$0.78 B8.69%
2007NZ$0.72 B-7.93%
2006NZ$0.78 B389.59%
2005NZ$0.16 B5.75%
2004NZ$0.15 B

End of Day market cap according to different sources

On Apr 2nd, 2025 the market cap of Halozyme Therapeutics was reported to be:

NZ$13.58 Billion
by Nasdaq info icon info icon
NZ$13.62 Billion
by CompaniesMarketCap info icon info icon
NZ$13.62 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$2.66 B-80.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.285 T 9,337.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.20 B 121.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$245.14 B 1,699.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$234.59 B 1,621.97%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$655.19 B 4,709.14%๐Ÿ‡บ๐Ÿ‡ธ USA